Results 91 to 100 of about 4,829 (180)

Optimal use of BTK inhibitors in Waldenström’s macroglobulinemia: combination or single drug approach?

open access: yesTherapeutic Advances in Hematology
Waldenström macroglobulinemia is an indolent B-cell lymphoma which although remains incurable, there are a lot of treatment options. Today, Bruton tyrosine kinase inhibitors have a central role in the management of the disease either as monotherapy or ...
Eirini Solia, Efstathios Kastritis
doaj   +1 more source

Early Integration of CAR T‐Cell Therapy in Mantle Cell Lymphoma: Expert Opinion in the Era of BTK Inhibitors

open access: yes
Hematological Oncology, Volume 44, Issue 6, November 2026.
Carlo Visco   +4 more
wiley   +1 more source

Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life study

open access: yesHaematologica, 2023
Pierre-Edouard Debureaux   +19 more
doaj   +1 more source

Pirtobrutinib in Richter syndrome: Outcomes from the named patient programme in Italy

open access: yes
British Journal of Haematology, Volume 209, Issue 5, Page 2302-2306, November 2026.
Isacco Ferrarini   +19 more
wiley   +1 more source

B cell receptor pathway in chronic lymphocytic leukemia: specific role of CC-292

open access: yesImmunoTargets and Therapy, 2014
Jon E Arnason,1 Jennifer R Brown21Beth Israel Deaconess Medical Center, 2CLL Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USAAbstract: Chronic lymphocytic leukemia (CLL) is the most common ...
Arnason JE, Brown JR
doaj  

Bruton tyrosine kinase inhibitors for multiple sclerosis. [PDF]

open access: yesNat Rev Neurol, 2023
Krämer J   +3 more
europepmc   +1 more source

Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small‐Molecule Oncology Drug Development

open access: yes
Clinical and Translational Science, Volume 19, Issue 11, November 2026.
Paridhi Gupta   +3 more
wiley   +1 more source

Efficacy and Safety of Bruton Tyrosine Kinase Inhibitors in Waldenström Macroglobulinemia: A Single-Center Retrospective Analysis. [PDF]

open access: yesCureus
Singh M   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy